Global cardiology specialist, Dr. Samir Kapadia from Cleveland Clinic, delivers session on advanced cardiac care at CK Birla Hospitals in Jaipur
Apollo Hospitals, one of India's leading healthcare providers, is making significant strides in the medical field. The organisation announced two major developments: the establishment of an oncology centre featuring next-generation proton therapy and the acquisition of IFC's 31% stake in Apollo Health & Lifestyle.
Dr. Prathap C Reddy, founder and chairman of the Apollo Hospitals Group, unveiled the plans for the oncology centre in Gurugram. This centre will be equipped with next-generation proton therapy, a cutting-edge technology in cancer treatment. The exact cost and timeline for the establishment of the centre were not disclosed.
Separate from the establishment of the oncology centre, Apollo Hospitals is planning to acquire IFC's 31% stake in Apollo Health & Lifestyle for a value of ₹1,254 crore. This acquisition is a related event to Apollo Health & Lifestyle, and further solidifies Apollo Hospitals' position in the healthcare industry.
Meanwhile, Artemis Hospitals has made a significant stride in cardiology with the unveiling of a Heart & Lung Transplant Centre in North India.
In another development, IIITH and Hexaware hosted an innovation challenge on Agentic AI for lifesciences, showcasing the continued emphasis on technological advancements in the healthcare sector.
These developments underscore Apollo Hospitals' commitment to providing people-centric and sustainable healthcare, a focus of the 3rd AHPI Leadership Summit. The summit aims to drive change and innovation in the healthcare industry, ensuring it remains accessible and effective for all.
